Sign in Subscribe
Scientists

Pharmacodynamic Model of Aurora Kinase Inhibitors in Cancer Therapy

Strategic Insights

— 2 min read

Researchers at the University of Dundee in Scotland have developed a novel mathematical modeling approach to study the role of Aurora kinases in cancer therapy. The pharmacodynamic model, presented in a recent report, aims to overcome the difficulty of linking inhibitor concentration and efficacy using standard methods. By encapsulating the key roles of Aurora A and B kinases in the spindle assembly checkpoint, the model can predict cell behavior and qualitatively differentiate between the effects of inhibiting Aurora A, Aurora B, and both simultaneously.

Key Takeaways:

  • The study's researchers propose a novel mathematical modeling approach to overcome the difficulty of linking inhibitor concentration and efficacy using standard methods.
  • The pharmacodynamic model encapsulates the key roles of Aurora A and B kinases in the spindle assembly checkpoint, allowing for predictions regarding the qualitative relationship between inhibitors, measurable biomarkers, and cell damage.
  • The model can qualitatively differentiate between the effects of inhibiting Aurora A, Aurora B, and both simultaneously by predicting cell behavior.
  • The study focuses on the importance of Aurora kinases in cancer therapy, specifically their role in the spindle assembly checkpoint.
  • The researchers' work was published in Frontiers In Bioscience in 2010.

Specific names mentioned include:

  • H.B. Mistry, lead researcher and mathematician at the University of Dundee
  • The University of Dundee, Division of Mathematics, Dundee DD1 4HN, Scotland

Contextual details and implications include:

  • The study's findings have significant implications for the development of cancer therapies targeting Aurora kinases
  • The pharmacodynamic model can aid in the design of more effective inhibitor concentrations and efficacy predictions
  • The research contributes to a better understanding of the complex roles of Aurora kinases in cancer therapy

Statistics:

  • 2 kinases, Aurora A and B, are key targets for cancer therapy (Opens in a new tab: [Aurora B kinase inhibitors in antineoplastic therapy](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716669/))
  • The study's pharmacodynamic model can predict cell behavior and differentiate between inhibitor effects using mathematical equations
  • The researchers' work was published in Frontiers In Bioscience in 2010, a peer-reviewed journal (Frontiers In Bioscience, 2010;15():249-58)
  • The study focuses on cancer therapy, specifically the role of Aurora kinases in the spindle assembly checkpoint

Sources:

  • Mistry, H.B., et al. (2010) A pharmacodynamic model of Aurora kinase inhibitors in the spindle assembly checkpoint. Frontiers In Bioscience, 15(3), 249-258.
  • Bioscience (2010) A pharmacodynamic model of Aurora kinase inhibitors in the spindle assembly checkpoint.
  • NewsRx.com (2010) Cancer Weekly editors, Cancer Weekly via NewsRx.com.

Read more